Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 30

    1.

    Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.

    De Luca A, Ammassari A, Pezzotti P, Cinque P, Gasnault J, Berenguer J, Di Giambenedetto S, Cingolani A, Taoufik Y, Miralles P, Marra CM, Antinori A; Gesida 9/99, IRINA, ACTG 363 Study Groups.

    AIDS. 2008 Sep 12;22(14):1759-67.PMID: 18753934 [PubMed - indexed for MEDLINE]Related articles

    2.

    Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.

    Marzocchetti A, Sanguinetti M, Giambenedetto SD, Cingolani A, Fadda G, Cauda R, De Luca A.

    J Neurovirol. 2007 Aug;13(4):338-46.PMID: 17849317 [PubMed - indexed for MEDLINE]Related articles

    3.

    Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure.

    De Luca A, Weidler J, Di Giambenedetto S, Coakley E, Cingolani A, Bates M, Lie Y, Pesano R, Cauda R, Schapiro J.

    J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):411-7.PMID: 17554216 [PubMed - indexed for MEDLINE]Related articles

    4.

    Three-year clinical outcomes of resistance genotyping and expert advice: extended follow-up of the Argenta trial.

    De Luca A, Di Giambenedetto S, Cingolani A, Bacarelli A, Ammassari A, Cauda R.

    Antivir Ther. 2006;11(3):321-7.PMID: 16759048 [PubMed - indexed for MEDLINE]Related articles

    5.

    Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients.

    Larussa D, Lorenzini P, Cingolani A, Bossolasco S, Grisetti S, Bongiovanni M, Moretti F, Uccella I, Zannoni P, Foresti S, Mazzarello G, Arcidiacono MI, Pedale R, Ammassari A, Tozzi V, Perno CF, Monforte AD, Cinque P, Antinori A; Italian Registry Investigative Neuro AIDS (IRINA).

    AIDS Res Hum Retroviruses. 2006 May;22(5):386-92.PMID: 16706614 [PubMed - indexed for MEDLINE]Related articles

    6.

    Acute promyelocytic leukemia in an HIV-infected patient: a case report.

    De Vita S, De Matteis S, Laurenti L, Sorà F, Tarnani M, Cingolani A, Sica S.

    Am J Hematol. 2006 Apr;81(4):300. No abstract available. PMID: 16550512 [PubMed - indexed for MEDLINE]Related articles

    7.

    Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.

    Cingolani A, Fratino L, Scoppettuolo G, Antinori A.

    J Neurovirol. 2005;11 Suppl 3:38-44. Review.PMID: 16540454 [PubMed - indexed for MEDLINE]Related articles

    8.

    Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy?

    Antinori A, Cingolani A, Perno CF.

    AIDS. 2005 Oct 14;19(15):1691-4. Review. No abstract available. PMID: 16184041 [PubMed - indexed for MEDLINE]Related articles

    9.

    Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy.

    Marzocchetti A, Di Giambenedetto S, Cingolani A, Ammassari A, Cauda R, De Luca A.

    J Clin Microbiol. 2005 Aug;43(8):4175-7.PMID: 16081969 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy.

    Marzocchetti A, Cingolani A, Giambenedetto SD, Ammassari A, Giancola ML, Cauda R, Antinori A, Luca AD.

    J Neurovirol. 2005 Apr;11(2):219-24.PMID: 16036800 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.

    Antinori A, Larussa D, Cingolani A, Lorenzini P, Bossolasco S, Finazzi MG, Bongiovanni M, Guaraldi G, Grisetti S, Vigo B, Gigli B, Mariano A, Dalle Nogare ER, De Marco M, Moretti F, Corsi P, Abrescia N, Rellecati P, Castagna A, Mussini C, Ammassari A, Cinque P, d'Arminio Monforte A; Italian Registry Investigative NeuroAIDS.

    Clin Infect Dis. 2004 Dec 1;39(11):1681-91. Epub 2004 Nov 5.PMID: 15578371 [PubMed - indexed for MEDLINE]Related articles

    12.

    Positive predictive value of Epstein-Barr virus DNA detection in HIV-related primary central nervous system lymphoma.

    Cinque P, Cingolani A, Bossolasco S, Antinori A.

    Clin Infect Dis. 2004 Nov 1;39(9):1396-7; author reply 1397-8. No abstract available. PMID: 15494920 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir.

    Laurenti L, Piccioni P, Cattani P, Cingolani A, Efremov D, Chiusolo P, Tarnani M, Fadda G, Sica S, Leone G.

    Haematologica. 2004 Oct;89(10):1248-52.PMID: 15477211 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.

    De Luca A, Vendittelli M, Baldini F, Di Giambenedetto S, Trotta MP, Cingolani A, Bacarelli A, Gori C, Perno CF, Antinori A, Ulivi G.

    Antivir Ther. 2004 Aug;9(4):583-93.PMID: 15456090 [PubMed - indexed for MEDLINE]Related articles

    15.

    Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients.

    De Luca A, Di Giambenedetto S, Cingolani A, Ammassari A, Marasca G, Tumbarello M, Fantoni M, Tamburrini E, Cauda R.

    AIDS. 2004 Jul 23;18(11):1602-4.PMID: 15238782 [PubMed - indexed for MEDLINE]Related articles

    16.

    The influence of hepatitis C virus coinfection on the risk of lipid abnormalities in a cohort of HIV-1-infected patients after initiation of highly active antiretroviral therapy.

    Di Giambenedetto S, Baldini F, Cingolani A, Tamburrini E, Cauda R, De Luca A.

    J Acquir Immune Defic Syndr. 2004 May 1;36(1):641-2. No abstract available. Erratum in: J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):882. PMID: 15097310 [PubMed - indexed for MEDLINE]Related articles

    17.

    Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics.

    De Luca A, Baldini F, Cingolani A, Di Giambenedetto S, Hoetelmans RM, Cauda R.

    J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):359-66.PMID: 15097152 [PubMed - indexed for MEDLINE]Related articles

    18.

    Clinical implications of HIV-1 drug resistance in the neurological compartment.

    Antinori A, Cingolani A, Giancola ML, Forbici F, De Luca A, Perno CF.

    Scand J Infect Dis Suppl. 2003;106:41-4. Review.PMID: 15000582 [PubMed - indexed for MEDLINE]Related articles

    19.

    Interpretation systems for genotypic drug resistance of HIV-1.

    De Luca A, Antinori A, Di Giambenedetto S, Cingolani A, Colafigli M, Perno CF, Cauda R.

    Scand J Infect Dis Suppl. 2003;106:29-34. Review.PMID: 15000579 [PubMed - indexed for MEDLINE]Related articles

    20.

    Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.

    De Luca A, Cingolani A, Di Giambenedetto S, Trotta MP, Baldini F, Rizzo MG, Bertoli A, Liuzzi G, Narciso P, Murri R, Ammassari A, Perno CF, Antinori A.

    J Infect Dis. 2003 Jun 15;187(12):1934-43. Epub 2003 May 22.PMID: 12792870 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...